Undulator magnet cores are essential for advanced applications such as synchrotron radiation sources, advanced chip manufacturing, and fusion technology. SLAC researchers have a new manufacturing approach that achieves greater precision at significantly lower costs.
Stanford researchers have developed ModulADAR - a novel RNA sensing platform that enables precise, cell-type or state-specific activation of mRNA expression using ADAR editing, offering unparalleled flexibility and specificity for targeted RNA therapeutics.
Hydrogen that is free of greenhouse gas (GHG) emissions is a key vector to fuel a net-zero emissions economy, but today's H2 is sourced from fossil fuels mostly by the highly emissions-intensive processes of steam methane reforming (SMR) or coal gasification.
Stanford University and University of Wisconsin–Madison researchers have developed a new device to achieve upconversion (UC) of incoherent near-infrared (NIR) photons beyond 1100nm to visible photons, through sensitized triplet–triplet annihilation (TTA).
Researchers in Prof. Amato Giaccia's laboratory have discovered that preventing Axl signaling can reduce tumor-related fibrosis. Axl is a receptor tyrosine kinase that is activated by its ligand, Gas6.
Stanford researchers have identified a novel approach to directly inhibit the receptor tyrosine kinase AXL (also known as UFO, ARK, and Tyro7) from interacting with its ligand, GAS6.
Researchers in the Stanford Urban Informatics Lab have developed a cost-effective, scalable, "no-touch" energy audit critical for decarbonization that uses physics-based simulations and machine learning to identify energy inefficiencies in buildings using only hourly electrici
Overweight and obesity are linked to an increased risk and worsened outcome from many cancers, including colorectal, pancreatic and breast cancer, but the mechanisms responsible for these phenomena are unknown.
Stanford researchers have defined subgroups of regulatory T cell (Tregs), CD39+ and CD39-, that can be genetically engineered to produce enhanced or reduced cytotoxicity without affecting their ability to suppress the immune system.
Scientists in the Carette Lab at Stanford have developed AAV-Titer cell lines that enable (1) improved and standardized in vitro potency assays (2) determination of a functional titer of AAV vectors of different serotypes and containing different promotors.
Stanford University and University Hospital Bonn scientists have discovered that mammalian IRES-like sequences can overcome the efficiency limitations of eukaryotic translation initiation in circular RNA therapeutics.
Stanford researchers have developed a novel methodology for the high-throughput expression and kinetic characterization of numerous enzyme variants in parallel using microfluidic droplet arrays.